HOME >> MEDICINE >> NEWS
ZYVOX(R) demonstrates high success rate for patients who develop MRSA surgical site infections

New York, Dec. 15, 2004 Surgical patients treated with Pfizer's novel antibiotic ZYVOX (linezolid; injection, tablets, and for oral suspension) had a significantly higher rate of microbiologic success (documented or presumed eradication) than those treated with intravenous (IV) vancomycin for surgical site infections (SSIs) caused by methicillin-resistant Staphylococcus aureus (MRSA), according to data published in the December issue of the American Journal of Surgery. In addition, the mean duration of IV treatment was significantly shorter (6 days) for patients who received ZYVOX than for those treated with vancomycin. Post-operative surgical site infections remain a major source of illness and number approximately 500,000 per year.

In the post-hoc analysis, patients in the MRSA subgroup treated with ZYVOX had microbiologic success rates of 87 percent compared to 48 percent for patients on vancomycin. Clinical cure rates for ZYVOX-treated patients were comparable to those treated with vancomycin for all SSIs, including those caused by MRSA. ZYVOX, available in interchangeable IV and oral formulations, is the only oral therapy approved by the U.S. Food and Drug Administration for MRSA infections.

Patients who develop SSIs are 60 percent more likely to spend time in an intensive care unit, five times more likely to be readmitted to the hospital and twice as likely to die. Hard-to-treat resistant bacteria such as MRSA are further complicating these infections. MRSA is extremely serious and can lead to prolonged hospitalization, increased morbidity, increased risk of mortality, and increased costs (driven by length of hospital stay). Data show that MRSA caused 30 percent of SSIs in 2000 compared to 24 percent in 1997.

"As the prevalence of surgical site infections caused by MRSA increases, identifying MRSA early and having alternatives to vancomycin becomes extremely important since any patient undergoing surgery is at risk," said
'"/>

Contact: Jeanne Traflet
Jeanne.Traflet@Pfizer.com
212-733-0127
Edelman Public Relations
15-Dec-2004


Page: 1 2 3 4 5

Related medicine news :

1. New study in Nature demonstrates protection against cell death during heart attack
2. New study demonstrates co-administration
3. New data demonstrates that Benicar(R) and Benicar HCT (TM) achieve JNC 7 blood pressure goals
4. New study demonstrates significant and sustained improvements in BPH symptoms with AVODART ™
5. New Canadian study demonstrates clear survival benefit of treatment in trials and at large centres
6. New study demonstrates key benefits of RISPERDAL(R) CONSTA(R) in young adults with schizophrenia
7. UF smart home demonstrates concept of automated elderly help and care
8. Study demonstrates improved survival in women with metastatic breast cancer
9. CHARM* Programme demonstrates clear benefits of Atacand in the treatment of heart failure
10. Residential addiction treatment demonstrates economic benefits
11. New P.E. study demonstrates vigorous exercise can lower adolescents body fat, blood pressure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... , ... August 31, 2020 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – today announced the 10th Anniversary of Blood Cancer Awareness Month (BCAM) and ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... solution for chiropractors, announced today the launch of its integrated, HIPAA compliant, telehealth ... running their virtual practice in under 90 seconds. , According to the ...
(Date:8/31/2020)... ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , ... in a state of panic, experiencing deep anxiety, immense stress, and right now are needing ... timely when most people on the planet are experiencing a great degree of emotional discomfort, ...
(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author Randy Pausch was diagnosed ... people would. Rather than become melancholic, however, he put together a final lecture in ... Randy Pausch took a negative situation and turned it into something that inspired millions ...
(Date:8/28/2020)... Ill. (PRWEB) , ... August 28, 2020 , ... ... The Nourished Group set out to continue helping the specialty-diet community ... can discover new gluten-free products, get coupons, enter giveaways, chat with brands & ...
Breaking Medicine News(10 mins):
(Date:8/28/2020)... ... August 28, 2020 , ... Cano Health, LLC, ... in Florida and San Antonio is happy to announce that it has selected ... In this capacity he will serve as community advisor, advertising talent, and creative ...
(Date:8/27/2020)... ... August 27, 2020 , ... Austin Oral Surgery – an ... to announce Dr. David Szalay, DDS, MD, has joined the practice. An accomplished oral ... new Pflugerville office, which is scheduled to open this fall. The new office is ...
(Date:8/27/2020)... ... ... Bridge To A Cure Foundation announces the appointment of Henry Friedman, M.D. ... serves on the Board of Directors at The Preston Robert Tisch Brain Tumor Center ... recognized, Dr. Friedman is a widely published author of more than 500 peer reviewed ...
Breaking Medicine Technology:
Cached News: